News

After a seven day jury trial, the jury unanimously decided that the SOLiD sequencing technology did not infringe the patent. “We are very pleased with the decisions by

Within the healthcare division, the company’s Imaging and IT segment was the top profit contributor in the first quarter of fiscal 2009, producing a profit of EUR262 million

This study, to be launched in both Canada and the US, will be an open, multi-center trial treating patients with addictions to assess the effectiveness of using the

High-end tests such as genetics and molecular biology, which are labour-intensive, are sent to India as they can be serviced at nearly one-eighth the costs of developed markets.

The double-blind, randomized, placebo-controlled 12-week study in up to 80 patients with confirmed eosinophilic esophagitis (EoE) aged two to 18 is designed to evaluate three different doses of

Todd Motto, vice president of sales and marketing, Meridian Bioscience commented, “Following a thorough evaluation of the Australian and Argentinean markets, it is clear that Immuno Pty and

Before joining Amylin, Mr Mihalik was vice president of global brand development diabetes and endocrine platform team leader at Eli Lilly and Company. Mr Mihalik will oversee marketing

The Phase I clinical trial was initiated to evaluate the safety, tolerability and pharmacokinetics of ON 01210.Na in healthy volunteers. Data from this initial trial will be used

The board also announced that it has commenced a search for a permanent replacement for departing president and CEO, Arie Cohen, who has left the company to pursue